Sensei Biotherapeutics, Inc. (SNSE)
30.00
-0.15
(-0.50%)
USD |
NASDAQ |
Apr 14, 12:00
Sensei Biotherapeutics Cash from Investing (TTM) : 14.54M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Johnson & Johnson | -23.59B |
| Vir Biotechnology, Inc. | 310.37M |
| Acurx Pharmaceuticals, Inc. | 0.00 |
| Tango Therapeutics, Inc. | -40.86M |
| Xilio Therapeutics, Inc. | -0.518M |